Wells Fargo & Company reduced its price target for CoreWeave to $125.00 from $150.00. The firm maintained an "Overweight" rating on the stock. Separately, DA Davidson upgraded the stock to "Neutral" from "Underperform."
These analyst actions come amid active discussions regarding the company’s financial strategy and leverage risks.
Adding to the developments, Pomerantz LLP announced an investigation on behalf of investors. The probe concerns whether CoreWeave engaged in securities fraud or other unlawful business practices. This investigation relates specifically to previously lowered 2025 guidance.
Separately, CoreWeave’s Chief Development Officer sold over $10 million in stock. The sale occurred on January 5th under a pre-arranged trading plan.